APA (7th ed.) Citation

S, R., S, L., V, F., P, F., MC, F., S, S., . . . MP, P. (2016). CTLA-4 in mesothelioma patients: Tissue expression, body fluid levels and possible relevance as a prognostic factor. Cancer immunology, immunotherapy : CII, 65(8), 909. https://doi.org/10.1007/s00262-016-1844-3

Chicago Style (17th ed.) Citation

S, Roncella, et al. "CTLA-4 in Mesothelioma Patients: Tissue Expression, Body Fluid Levels and Possible Relevance as a Prognostic Factor." Cancer Immunology, Immunotherapy : CII 65, no. 8 (2016): 909. https://doi.org/10.1007/s00262-016-1844-3.

MLA (9th ed.) Citation

S, Roncella, et al. "CTLA-4 in Mesothelioma Patients: Tissue Expression, Body Fluid Levels and Possible Relevance as a Prognostic Factor." Cancer Immunology, Immunotherapy : CII, vol. 65, no. 8, 2016, p. 909, https://doi.org/10.1007/s00262-016-1844-3.